Cumberland Total Assets from 2010 to 2025

CPIX Stock

USD 4.59 0.29 5.94%

Cumberland Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2006-12-31

Previous Quarter

76.7 M

Current Value

75.6 M

Quarterly Volatility

23.9 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.3 M, Interest Expense of 635.8 K or Selling General Administrative of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.84, Dividend Yield of 0.0 or PTB Ratio of 0.0. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.

For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Cumberland Pharmaceuticals over the last few years. Total assets refers to the total amount of Cumberland Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cumberland Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Cumberland Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 75.58 T

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Cumberland Total Assets Regression Statistics

	Arithmetic Mean	9,684,201,826,722
	Geometric Mean	449,774,528
	Coefficient Of Variation	273.34
	Mean Deviation	Huge
	Median	95,405,114
	Standard Deviation	Huge
	Sample Variance	700715387375545.9T
	Range	79.4T
	R-Value	0.57
	Mean Square Error	502761105115309.1T
	R-Squared	0.33
	Significance	0.02
	Slope	3,195,619,860,251
	Total Sum of Squares	10510730810633188T

Cumberland Total Assets History

	2025	79.4 T
	2024	75.6 T
	2023	81.8 M
	2022	92.9 M
	2021	84.5 M
	2020	96.5 M
	2019	104.5 M

Other Fundumenentals of Cumberland Pharmaceuticals

Intangibles To Total Assets

Cumberland Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Long Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.35	1.0	-1.0	0.24	1.0	1.0	1.0	1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Total Stockholder Equity	1.0		0.35	1.0	-1.0	0.24	1.0	1.0	1.0	1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Current Deferred Revenue	0.35	0.35		0.35	-0.35	0.4	0.35	0.35	0.35	0.35	0.55	0.31	0.35	0.23	-0.46	0.25	0.28	-0.34	-0.38	-0.37
Net Debt	1.0	1.0	0.35		-1.0	0.24	1.0	1.0	1.0	1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Retained Earnings	-1.0	-1.0	-0.35	-1.0		-0.26	-1.0	-1.0	-1.0	-1.0	0.08	-0.05	-1.0	-0.22	0.46	-0.24	-0.32	0.67	0.62	0.77
Accounts Payable	0.24	0.24	0.4	0.24	-0.26		0.24	0.24	0.24	0.24	0.71	0.81	0.24	0.56	-0.89	0.87	0.52	-0.65	-0.77	-0.36
Net Receivables	1.0	1.0	0.35	1.0	-1.0	0.24		1.0	1.0	1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Total Liab	1.0	1.0	0.35	1.0	-1.0	0.24	1.0		1.0	1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Total Current Assets	1.0	1.0	0.35	1.0	-1.0	0.24	1.0	1.0		1.0	-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Short Term Debt	1.0	1.0	0.35	1.0	-1.0	0.24	1.0	1.0	1.0		-0.08	0.05	1.0	0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Intangible Assets	-0.08	-0.08	0.55	-0.08	0.08	0.71	-0.08	-0.08	-0.08	-0.08		0.74	-0.08	0.45	-0.71	0.64	0.22	-0.19	-0.44	-0.14
Long Term Debt	0.05	0.05	0.31	0.05	-0.05	0.81	0.05	0.05	0.05	0.05	0.74		0.05	0.59	-0.79	0.95	0.31	-0.39	-0.66	-0.28
Common Stock	1.0	1.0	0.35	1.0	-1.0	0.24	1.0	1.0	1.0	1.0	-0.08	0.05		0.22	-0.46	0.23	0.32	-0.66	-0.62	-0.79
Property Plant Equipment	0.22	0.22	0.23	0.22	-0.22	0.56	0.22	0.22	0.22	0.22	0.45	0.59	0.22		-0.59	0.61	-0.01	-0.39	-0.61	-0.37
Net Tangible Assets	-0.46	-0.46	-0.46	-0.46	0.46	-0.89	-0.46	-0.46	-0.46	-0.46	-0.71	-0.79	-0.46	-0.59		-0.84	-0.49	0.79	0.93	0.67
Long Term Debt Total	0.23	0.23	0.25	0.23	-0.24	0.87	0.23	0.23	0.23	0.23	0.64	0.95	0.23	0.61	-0.84		0.35	-0.54	-0.77	-0.36
Short Long Term Debt	0.32	0.32	0.28	0.32	-0.32	0.52	0.32	0.32	0.32	0.32	0.22	0.31	0.32	-0.01	-0.49	0.35		-0.47	-0.36	-0.36
Net Invested Capital	-0.66	-0.66	-0.34	-0.66	0.67	-0.65	-0.66	-0.66	-0.66	-0.66	-0.19	-0.39	-0.66	-0.39	0.79	-0.54	-0.47		0.91	0.77
Net Working Capital	-0.62	-0.62	-0.38	-0.62	0.62	-0.77	-0.62	-0.62	-0.62	-0.62	-0.44	-0.66	-0.62	-0.61	0.93	-0.77	-0.36	0.91		0.79
Capital Stock	-0.79	-0.79	-0.37	-0.79	0.77	-0.36	-0.79	-0.79	-0.79	-0.79	-0.14	-0.28	-0.79	-0.37	0.67	-0.36	-0.36	0.77	0.79

Click cells to compare fundamentals

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	75.6 T	79.4 T
Intangibles To Total Assets	0.25	0.18

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC